Atlas Trials

Multiple Myeloma (MM)

69 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Multiple Myeloma (MM)

RecordFirmDate
Phase I Trial of GR1803 Injection in Patients With RRMM (NCT07102706)Genrix (Shanghai) Biopharmaceutical Co., Ltd.2022-05-27
Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM) (NCT04721002)AbbVie2021-07-07
VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) (NCT04702425)Novartis Pharmaceuticals2021-06-23
Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT04649073)Otsuka Pharmaceutical Co., Ltd.2021-02-18
Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies (NCT05513612)Shanghai Pudong Hospital2020-08-01
A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma (NCT04178902)AbbVie2020-05-19
A Study of WVT078 in Patients With Multiple Myeloma (MM) (NCT04123418)Novartis Pharmaceuticals2019-12-05
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications (NCT03018405)Celyad Oncology SA2016-12-01
Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma. (NCT02203643)Mario Boccadoro2015-02-01
An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma (NCT02211014)Acerta Pharma BV2015-02-01
Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer (NCT02240537)Benovus Bio, Inc.2015-01-01
Study Evaluating Venetoclax in Subjects With Hematological Malignancies (NCT02265731)AbbVie2014-09-22
Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma (NCT02920697)Institut de Recherches Internationales Servier2014-03-01
Phase I Study of Milatuzumab for Graft Versus Host Disease (NCT01663766)Gilead Sciences2013-12-01
Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma (NCT01919086)Memorial Sloan Kettering Cancer Center2013-08-06
Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies (NCT01413568)Polyphor Ltd.2012-04-01
Tumor Registry of Lymphatic Neoplasia (NCT00889798)iOMEDICO AG2009-04-01
Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies (NCT00710528)Gilead Sciences2008-06-01

Track Multiple Myeloma (MM) automatically

Every clearance here is in the API, with alerts when new ones post.